{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:40:08Z","timestamp":1747064408140,"version":"3.40.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05253-8","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T02:33:41Z","timestamp":1747017221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuta","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Tokumitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Matsukuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"1","key":"5253_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.510290145","volume":"29","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et\u00a0al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29(1):62\u20137.","journal-title":"Hepatology"},{"issue":"1","key":"5253_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et\u00a0al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"36","key":"5253_CR3","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1200\/JCO.20.02672","volume":"38","author":"JD Gordan","year":"2020","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, et\u00a0al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline. J Clin Oncol. 2020;38(36):4317\u201345.","journal-title":"J Clin Oncol"},{"key":"5253_CR4","first-page":"1","volume":"40","author":"M Qadan","year":"2020","unstructured":"Qadan M, Kothary N, Sangro B, Palta M. The treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Am Soc Clin Oncol Educ Book. 2020;40:1\u20138.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"9","key":"5253_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jhbp.574","volume":"25","author":"E Hatano","year":"2018","unstructured":"Hatano E, Uemoto S, Yamaue H, Yamamoto M, Japanese Society of Hepato-Biliary-Pancreatic S. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese society of hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci. 2018;25(9):395\u2013402.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"5253_CR6","volume-title":"General rules for the clinical and pathological study of primary liver cancer","author":"Liver Cancer Study Group of Japan","year":"2010","unstructured":"Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 3rd ed. Kanehara: Liver Cancer Study Group of Japan; 2010.","edition":"3"},{"issue":"1","key":"5253_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52\u201360.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"5253_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"1","key":"5253_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/hepr.13438","volume":"50","author":"M Kudo","year":"2020","unstructured":"Kudo M, Izumi N, Kubo S, Kokudo N, Sakamoto M, Shiina S, et\u00a0al. Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2020;50(1):15\u201346.","journal-title":"Hepatol Res"},{"issue":"11","key":"5253_CR10","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s10620-007-9808-2","volume":"52","author":"D Takizawa","year":"2007","unstructured":"Takizawa D, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, et\u00a0al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci. 2007;52(11):3290\u20135.","journal-title":"Dig Dis Sci"},{"issue":"20","key":"5253_CR11","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et\u00a0al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"4","key":"5253_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et\u00a0al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862\u201373.","journal-title":"J Hepatol."},{"issue":"5","key":"5253_CR13","first-page":"821","volume":"108","author":"K Kumada","year":"1990","unstructured":"Kumada K, Ozawa K, Okamoto R, Takayasu T, Yamaguchi M, Yamamoto Y, et\u00a0al. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery. 1990;108(5):821\u20137.","journal-title":"Surgery"},{"issue":"10","key":"5253_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/hepr.12923","volume":"47","author":"K Sakamoto","year":"2017","unstructured":"Sakamoto K, Nagano H. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatol Res. 2017;47(10):957\u201362.","journal-title":"Hepatol Res"},{"issue":"5","key":"5253_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","volume":"65","author":"T Kokudo","year":"2016","unstructured":"Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et\u00a0al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65(5):938\u201343.","journal-title":"J Hepatol"},{"issue":"5","key":"5253_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5582\/bst.2017.01210","volume":"11","author":"T Higaki","year":"2017","unstructured":"Higaki T, Yamazaki S, Moriguchi M, Nakayama H, Kurokawa T, Takayama T. Indication for surgical resection in patients with hepatocellular carcinoma with major vascular invasion. Biosci Trends. 2017;11(5):581\u20137.","journal-title":"Biosci Trends"},{"issue":"11","key":"5253_CR17","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23033","volume":"110","author":"H Nagano","year":"2007","unstructured":"Nagano H, Miyamoto A, Wada H, Ota H, Marubashi S, Takeda Y, et\u00a0al. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer. 2007;110(11):2493\u2013501.","journal-title":"Cancer"},{"issue":"9","key":"5253_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4254\/wjh.v10.i9.571","volume":"10","author":"I Saeki","year":"2018","unstructured":"Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Fujisawa K, et\u00a0al. Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy. World J Hepatol. 2018;10(9):571\u201384.","journal-title":"World J Hepatol"},{"issue":"5","key":"5253_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.bjc.6602742","volume":"93","author":"H Ota","year":"2005","unstructured":"Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, et\u00a0al. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer. 2005;93(5):557\u201364.","journal-title":"Br J Cancer"},{"issue":"29","key":"5253_CR20","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.3748\/wjg.v19.i29.4679","volume":"19","author":"DS Song","year":"2013","unstructured":"Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, et\u00a0al. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2013;19(29):4679\u201388.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5253_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/bjc.2013.542","volume":"109","author":"K Nouso","year":"2013","unstructured":"Nouso K, Miyahara K, Uchida D, Kuwaki K, Izumi N, Omata M, et\u00a0al. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide survey of primary liver cancer in Japan. Br J Cancer. 2013;109(7):1904\u20137.","journal-title":"Br J Cancer"},{"issue":"6","key":"5253_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2468-1253(18)30078-5","volume":"3","author":"M Kudo","year":"2018","unstructured":"Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, et\u00a0al. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(6):424\u201332.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"5253_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000513706","volume":"10","author":"Y Kosaka","year":"2021","unstructured":"Kosaka Y, Kimura T, Kawaoka T, Ogawa Y, Amioka K, Naruto K, et\u00a0al. Hepatic arterial infusion chemotherapy combined with radiation therapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk or bilobar of the portal vein. Liver Cancer. 2021;10(2):151\u201360.","journal-title":"Liver Cancer"},{"issue":"11","key":"5253_CR24","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"JM Straub","year":"2015","unstructured":"Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1985\u201394.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"5253_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000535514","volume":"13","author":"A Ichida","year":"2024","unstructured":"Ichida A, Arita J, Hatano E, Eguchi S, Saiura A, Nagano H, et\u00a0al. A multicenter phase 2 trial evaluating the efficacy and safety of preoperative lenvatinib therapy for patients with advanced hepatocellular carcinoma (LENS-HCC trial). Liver Cancer. 2024;13(3):322\u201334.","journal-title":"Liver Cancer"},{"issue":"1","key":"5253_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12885-023-11302-6","volume":"23","author":"M Okuno","year":"2023","unstructured":"Okuno M, Ishii T, Ichida A, Soyama A, Takemura N, Hirono S, et\u00a0al. Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab. BMC Cancer. 2023;23(1):780.","journal-title":"BMC Cancer"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05253-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:03:57Z","timestamp":1747062237000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05253-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5253"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05253-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this research project was approved by a suitably constituted Ethics Committee of Yamaguchi University (approval no. 2020\u2013162). Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}